Aprepitant versus Olanzapine in Patients of Breast Cancer on Adriamycin and Cyclophosphamide Regimen – Role in Effectiveness of Prevention of Nausea and Vomiting

Aprepitant versus Olanzapine in Patients of Breast Cancer on Adriamycin and Cyclophosphamide Regimen – Role in Effectiveness of Prevention of Nausea and Vomiting

Background: Chemotherapy-induced nausea and vomiting (CINV) is a significant concern for patients undergoing highly emetogenic chemotherapy (HEC). This study compares the efficacy of aprepitant and olanzapine in preventing CINV in breast cancer patients receiving Adriamycin and Cyclophosphamide (AC...

Full description

Saved in:
Bibliographic Details
Main Authors: Indrani Devi Sarma, Sukainnya Buragohain, Joonmoni Lahon, Indrani Bhagawati, Neelakshi Mahanta, Dibyajyoti Saikia
Format: Article
Language:English
Published: Vilnius University Press 2025-06-01
Series:Acta Medica Lituanica
Subjects:
Olanzapine
Aprepitant
Chemotherapy-Induced Nausea and Vomiting (CINV)
breast cancer
Highly Emetogenic Chemotherapy (HEC)
Antiemesis
Online Access:https://www.journals.vu.lt/AML/article/view/38736
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.journals.vu.lt/AML/article/view/38736

Similar Items